Gubra’s once-weekly obesity candidate was tied to 3% weight loss during a six-week phase 1 trial, with a single injection ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

DehydraTECH clinical test article manufacturing has been completed KELOWNA, BC / ACCESSWIRE / November 13, 2024 / Lexaria ...

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results ...

GLP-1 RA: Glucagon-like peptide-1 (GLP-1 ... [7] Exenatide extended release: A long-acting RA version of exenatide ...